Skip to content
Oncology Research Hub

Commack, New York

Cancer clinical trials in Commack, NY

131 cancer studies are recruiting participants at sites in Commack as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Commack at a glance

  • 131 studies are recruiting at a site in Commack.
  • By phase: Phase 1 (16), Phase 1/2 (8), Phase 2 (55), Phase 2/3 (1), Phase 3 (16), Phase 4 (3), No phase (13), Observational (19). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (114), industry (9), government (8).
  • By research area: Breast Cancer (46), Lung Cancer (34), Lymphoma (24), Prostate Cancer (14), Pancreatic Cancer (10), Melanoma (3).
  • Most recent update to one of these records: November 16, 2026.

Breast cancer studies recruiting in Commack

Basic details from each study's public record (the 30 most recently updated of 131). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT07488676 · updated
  2. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT05564377 · updated
  3. A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

    • Phase 3
    • Ages 18 to 75
    • Female participants
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Commack (Limited Protocol Activities)
    Registry record
    NCT06144164 · updated
  4. A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy

    • Phase 2
    • Ages 18 and older
    • Female participants
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities )
    Registry record
    NCT07918989 · updated
  5. Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

    • Observational
    • Ages 18 and older
    • Female participants
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)
    Registry record
    NCT05590949 · updated
  6. A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk- Commack (Consent Only)
    Registry record
    NCT07218250 · updated
  7. MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
    Registry record
    NCT06954337 · updated
  8. A Study of Skipping Radiation Therapy in People With Breast Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities )
    Registry record
    NCT07895511 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Commack, NY on ClinicalTrials.gov.

Lung cancer studies recruiting in Commack

  1. A Study of Armored CAR T Cells in People With Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities)
    Registry record
    NCT07783477 · updated
  2. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT04181060 · updated
  3. A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT07293247 · updated
  4. A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
    Registry record
    NCT06807632 · updated
  5. Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT01639508 · updated
  6. A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
    Registry record
    NCT06741085 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Commack, NY on ClinicalTrials.gov.

Prostate cancer studies recruiting in Commack

  1. Radiation Therapy Approaches for People With Prostate Cancer

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)
    Registry record
    NCT07751159 · updated
  2. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT03866382 · updated
  3. A Study of Changes to Prostate Procedures

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk-Commack (Consent only)
    Registry record
    NCT06986083 · updated
  4. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT06931340 · updated
  5. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT07200830 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Commack, NY on ClinicalTrials.gov.

Lymphoma studies recruiting in Commack

  1. Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT02974647 · updated
  2. Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT04269902 · updated
  3. Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT04301076 · updated
  4. Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT04840602 · updated
  5. Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Cancer Center @ Commack
    Registry record
    NCT03618550 · updated
  6. A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Suffolk - Commack
    Registry record
    NCT07231952 · updated
  7. Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT04803201 · updated
  8. Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT07215910 · updated
  9. A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

    • Phase 2
    • Ages 65 to 80
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Study site
    Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities)
    Registry record
    NCT06765317 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Commack, NY on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Commack

  1. APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT04858334 · updated
  2. A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Memorial Sloan Kettering Commack
    Registry record
    NCT07409272 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Commack, NY on ClinicalTrials.gov.

Ask about studies near Commack

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in New York

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call